01-04-2024 | Urothelial Cancer | Case report
Enfortumab-vedotin
Steven-Johnson syndrome/toxic epidermal necrolysis-like blistering reaction
Published in: Reactions Weekly | Issue 1/2024
Login to get accessExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event